  Artificial Intelligence (AI) is being adopted across the world and promises a
new revolution in healthcare. While AI-enabled medical devices in North America
dominate 42.3% of the global market, the use of AI-enabled medical devices in
other countries is still a story waiting to be unfolded. We aim to delve deeper
into global regulatory approaches towards AI use in healthcare, with a focus on
how common themes are emerging globally. We compare these themes to the World
Health Organization's (WHO) regulatory considerations and principles on ethical
use of AI for healthcare applications. Our work seeks to take a global
perspective on AI policy by analyzing 14 legal jurisdictions including
countries representative of various regions in the world (North America, South
America, South East Asia, Middle East, Africa, Australia, and the
Asia-Pacific). Our eventual goal is to foster a global conversation on the
ethical use of AI in healthcare and the regulations that will guide it. We
propose solutions to promote international harmonization of AI regulations and
examine the requirements for regulating generative AI, using China and
Singapore as examples of countries with well-developed policies in this area.
